The elevated expression levels of TNF-α and Th2 cytokines were decreased by kushenol F treatment, which suggested that kushenol F may help to reduce TSLP production, the infiltration of immune cells and itching behavior, which may potentially synergistically alleviate cutaneous inflammation in AD-like skin lesions (Figure 7). This evidence concerns the gene TSLP and Alzheimer disease.